Prognostic value of serum analyses of S-100 beta protein in malignant melanoma
von Schoultz, E, Hansson, L O, Djureen, E, Hansson, J, Kärnell, R, Nilsson, B, Stigbrand, T, Ringborg, U
Published in Melanoma research (01.04.1996)
Published in Melanoma research (01.04.1996)
Get more information
Journal Article
The value of cysteinyldopa in the follow-up of disseminated malignant melanoma
Kärnell, R, Kågedal, B, Lindholm, C, Nilsson, B, Arstrand, K, Ringborg, U
Published in Melanoma research (01.08.2000)
Published in Melanoma research (01.08.2000)
Get more information
Journal Article
S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma
Kärnell, R, von Schoultz, E, Hansson, L O, Nilsson, B, Arstrand, K, Kågedal, B
Published in Melanoma research (01.10.1997)
Published in Melanoma research (01.10.1997)
Get more information
Journal Article
Oncology consulting team. To optimize the support and treatment of cancer patients outside oncology departments
Gustafsson, E., Kärnell, R., Roström Björn, I., Rundström, C., Westman, B., Wikman, K., Ridderström, G., Asp, I., Harmenberg, U., Avallon, U.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
Screening for cutaneous malignant melanoma: a feasibility study
Törnberg, S, Månsson-Brahme, E, Lindén, D, Ringborg, U, Krakau, I, Kärnell, R, Landegren, J, Brandberg, Y, Hakulinen, T
Published in Journal of medical screening (1996)
Published in Journal of medical screening (1996)
Get more information
Journal Article